CAS: 49863-47-0; (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-Diamino-3-(((2R,3R,4R,5R)-3,5-Dihydroxy-5-Methyl-4-(Methylamino)Tetrahydro-2H-Pyran-2-yl)Oxy)-2-Hydroxycyclohexyl)Oxy)-2-((R)-1-Hydroxyethyl)Tetrahydro-2H-Pyran-3,4-Diol

上下游产品

链霉素 Streptomicin 57-92-1

📜,Lipofectamine,,Penicillin G Potassium,链霉素,G418 Disulfate 以to Obtain A Stable,G418-Resistant Strain的收率获得产物遗传霉素
参考文献:2H-Chromene Compound And Derivative Thereof
标题:2H-Chromene Compound And Derivative Thereof
摘要:提供了一种2H-色烯化合物或其衍生物,具有优异的s1P1激动剂作用.该2H-色烯化合物或衍生物特别适用于预防和/或治疗由不良淋巴细胞浸润引起的疾病或由细胞异常增殖或堆积引起的疾病.

专利信息

专利号:EP-0386563-B1
优先权日:1989-03-09
标 题:Antisense-oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (Tat) of HIV-I, and their use
发明人：STROPP UDO DR; BAUMGARTEN JOERG DR; LOEBBERDING ANTONIUS DR; SPRINGER WOLFGANG DR; PIEL NORBERT DR; KRETSCHMER AXEL DR; KOELBL HEINZ DR Z ZT MOBAY COR; FROMMER WERNER PROF DR
权利人:BAYER AG
摘要:The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have antiviral effects. The pharmaceuticals can be used for the therapy of HIV infections. The antisense oligonucleotides are suitable as gene probes for detecting HIV.

专利号:WO-0012554-A1
优先权日:1998-08-28
标题:Method for marked chemokine synthesis, marked chemokine and analysis kit
发明人：VITA CLAUDIO; VIZZAVONA JEAN; GLUCKMAN JEAN CLAUDE; BENJOUARD ABDELAZIZ
权利人:COMMISSARIAT ENERGIE ATOMIQUE; UNIV PARIS CURIE; VITA CLAUDIO; VIZZAVONA JEAN; GLUCKMAN JEAN CLAUDE; BENJOUARD ABDELAZIZ
摘要:The invention concerns a method for the homogeneous synthesis of a marked chemokine in a specific position. The invention also concerns a chemokine obtained by said method, a composition and a kit comprising said chemokine. The invention is characterised in the method for the synthesis of the marked chemokine comprises a step which consists in a solid phase chemical synthesis of the chemokine or a modified sequence thereof.

专利号:US-7411003-B1
优先权日:2007-07-09
标 题:Inhibition of Hepatitis B virus by cyclohexenone compounds from Antrodia camphorata
发明人：LIU SHENG-YUN; KUO MAO-TIEN; WEN WU-CHE
权利人:GOLDEN BIOTECHNOLOGY CORP
摘要:The present invention relates to a compound of Antrodia camphorata used to inhibit HBV, in particular to an extract, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone which is isolated from Antrodia camphorata, and its use in inhibiting HBV effectively. The cyclohexenone compound according to the present invention showed cytotoxicity on HBV-secreting human hepatoma cell line HepG2 2.2.15, decreased synthesis of HBV particles, further inhibited synthesis of HbsAg and HbeAg effectively to achieve the goal of HBV inhibition.

专利号:US-7700332-B1
优先权日:1999-05-21
标 题:Methods for the synthesis of lactic acid using crabtree-negative yeast transformed with the lactate dehydrogenase gene
发明人：RAJGARHIA VINEET; HATZIMANIKATIS VASSILY; OLSON STACEY; CARLSON TING; STARR JOHN N; KOLSTAD JEFFREY J; EYAL AHARON
权利人:CARGILL INC
摘要:The invention provides methods and materials related to the production of lactic acid. Specifically, the invention provides methods for producing lactic acid using a crabtree-negative yeast, such as of the Kluyveromyces, Pichia, Candida, Trichosporon and Yamadazmya genera, which have been transformed with a lactate dehydrogenase gene.

专利号:US-8007994-B2
优先权日:1998-12-10
标题:Compositions and methods of modulating cholesterol metabolism
发明人：MANGELSDORF DAVID J; REPA JOYCE J; TURLEY STEPHEN D; DIETSCHY JOHN M
权利人:UNIV TEXAS
摘要:The present invention relates to compositions and methods for reducing cholesterolemia and its effects. More specifically, the invention is directed, in one embodiment, to methods for screening for compounds that affect cholesterol levels generally, and in particular, that affect the absorption of cholesterol. The invention also is directed to methods of screening for compounds that increase bile acid synthesis. In so doing, the inventors describe useful transgenic cells and animals which lack one or both alleles of the LXRα gene. Also provided are therapeutic methods designed to reduce cholesterol levels in suitable subjects. The reduction may be effected by decreasing cholesterol absorption, increasing bile acid synthesis, or combinations thereof. Particularly useful in decreasing cholesterol absorption are RXR agonists, for example, rexinoid compounds. Therapeutic intervention in cholesterol biosynthesis and diet are additional adjunct therapies. In addition, the present invention relates to candidate compounds that modulate the expression of ABC-1 in a cell that expresses RXR. Methods of identifying and making a modulator of ABC-1 are disclosed.

专利号:US-2013102730-A1
优先权日:2010-04-02
标 题:Polyamine-containing polymers and methods of synthesis and use
发明人：JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN
权利人:JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN; ALBERTA INNOVATES TECHNOLOGY FUTURES
摘要:The present invention relates to polyamine-containing polymers and methods of their synthesis and use. The polymer may be hydroxyethylcellulose, dextran, poly(vinyl alcohol) or poly(methyl acrylate).